A Curated Platform of Equity & Options Market Intelligence
Select Page

AXNX

Search by
TICKER SYMBOL

Axonics Inc

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing

56.02

1.14

(2.077%)

Volume:

634,691

52 week range:

38.41 - 79.92

Market Cap:

2.799B

Company Description:

Based in Irvine, Calif., Axonics has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for patients with bladder and bowel dysfunction, and through its acquisition of Bulkamid®, offers a best-in-class urethral bulking agent for women with stress urinary incontinence. These conditions significantly impact quality of life. Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. Stress urinary incontinence affects an estimated 20 million women in the U.S. alone. Axonics' clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries.